CONFERENCE PRESENTATIONS
Presentations from the 2021 Southern African HIV Clinicians Society (SAHCS) conference will be shared after the conference has concluded.
Copies of the previous SAHCS conference are listed below.
—————————————————————————————————————————————————————
Southern African HIV Clinicians Society Conference 2018 – Presentations:
Pre-conference workshop A
- Basics to understand HIV drug resistance | Carole Wallis
- How do we measure HIV drug resistance | Monique Nijhuis
- Impact of ART resistance in sub Saharan Africa | Elliot Raizes
- Barriers to adherence: predictors and markers of treatment response | John de Wit
- Understanding virological failure | Annemarie Wensing
- Integrated adherence counselling using biomedical and socio-economic information | Lucas Hermans
- Therapy success and failure: first, second and third line therapy | Francois Venter
- DTG Global roll out | Ava Avalos
- Future trends of drug resistance and prospects of antiviral therapy | Douglas Richman
Pre-conference workshop B
- How to administer PrEP: a typical clinical consultation | Muhangwi Mulaudzi
Session 1A
- Previously on PrEP, now pregnant. What to do? | Tshidi Sebitloane
- Teen adherence | Juliet Houghton
- Breast abnormalities in adolescents receiving ART | Jackie Dunlop
Session 1B
- Case presentation: Treatment experienced and PrEP | Eric Hefer
- Case presentation: Pirates of the abdomen | Kim Pieton
- Case presentation: A palatal mass and a head-scratcher | Michelle Venter
Session 1C
- Cases – primary healthcare, rural doctors | Ndiviwe Mphothulo, Jenny Nash
- Managing HIV and the role of the primary healthcare team | Jenny Nash
- Missed Clinical Management Opportunities | Gloria Mthombeni
- Nurse cases | Talitha Crowley
Session 3
- Opening | Desmond Martin
- HIV replication: principles and prevention | Douglas Richman
Session 4A
- Not deaf or dead! The seven-year journey of bedaquiline as a third choice for all South Africans with MDR-TB, as told by one fortunate MDR-TB survivor | Arne von Delft
- Stop Stockouts Project and launch of the 4th annual medicine availability survey | Tinne Gils
Session 5
- How are we doing with Universal Test and Treat? | Francois Venter
- How are we doing with viral suppression? | Sergio Carmona
- Pretreatment drug resistance and new treatment paradigms in first-line ART | Michelle Moorhouse
Session 6A
- Pharmacovigilance | Karen Cohen
- Pregnancy register | Mukesh Dheda
- Registers and centralised reporting | Ruth Lancaster
Session 6B
- Swallowing tablets | Melanie Collins
- Optimising formulations | Carol Ruffell
- The latest on infant testing, and how to access | Gayle Sherman
- Treating children | Helena Rabie
Session 6C
- Whistle-blowing in the health-sector | Marije Versteeg-Mojanaga
- Ethics on how health budgets are split | Marije Versteeg-Mojanaga
Session 8A
- Kaposi Sarcoma and Lymphoma | Zainab Mohamed
Session 8B
- Viral resistance first-line and second-line | Graeme Meintjes
- Third-line treatment. Feedback on outcome of patients on national third-line regimen | Michelle Moorhouse
Session 8C
- Non-biomedical approaches | Sue Goldstein
- Condoms | Mags Beksinska
- Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches | Fatima Laher
- Voluntary medical male circumcision | Limakatso Lebina
- Treatment as prevention | Francois Venter
Session 9A
- NRTIs (Yunus Moosa)
- NNRTIs (Michelle Moorhouse)
- Drug-drug interaction (Gary Maartens)
Session 9C
- What are the numbers telling us | Andrew Boulle
- How the epidemic informs resource planning | Zukiswa Pinini
- Cost effectiveness of TLD versus TEE | Gesine Meyer-Rath
Session 10A
- HIVDB genotypic drug resistance interpretation program | Robert Shafer
Session 10B
- Integrating HIV prevention with other services | Natasha Davies
- How to tell a teenager they have HIV: A practical approach | Julia Turner
- Uptake and yield of a 24/7 HIV testing service across four Eastern Cape hospital Emergency departments | Dave Stead
Session 11
- Implications of scarcer resources for 90:90:90 | Gloria Maimela
Session 12
- Why do we need cure | John Mellors
- How do you measure cure | Monique Nijhuis
Session 13A
- An approach to intracranial mass lesions in HIV patients | Dave Stead
- Endemic mycoses in HIV patients | Jade Mogambery
- An approach to chronic diarrhoea | Sipho Dlamini
Session 13B
- TB in adults and HIV-TB co-infection | Ndiviwe Mphothulo
- TB and HIV co-infection including IRIS | Richard Lessells
Session 13C
- Injecting drug users in the region | Andrew Scheibe
- Engaging with sex workers | Naomi Hill
- Testing in taxi ranks | Thandeka Khoza
Session 15
Session 16A
- Case presentation | Farai Russell Sigauke
- Clinical skill building | Richard Lessells
Session 16B
- Should the private sector be treating TB? Yes | Moeketsi Mathe
Session 16C
- Where are we with PMTCT, including epidemiology | Landon Myer
- Transmission of HIV in breastfeeding | Ameena Goga
- Pregnant women on ART – programmatic issues | Coceka Mnyani
Session 17
- Dolutegravir in pregnancy – overview | Landon Myer
- DolPHIN-1 | Catherine Orrell
- Dolutegravir rollout | Steven Smith
Session 19
- Vaccinations – overview | Benjamin Kagina
- Influenza vaccines | Marta Nunes
- SAHCS vaccination guidelines | Sipho Dlamini
Session 20A
- Inflammation | Dave Spencer
- Hypertension | Ebrahim Variava
- Obesity | Denasha Reddy
- Mental health | John Joska
- Injection drug use, HIV and hepatitis | Moeketsi Mathe
Session 20B
- Ethico-legal framework for biobank research in SA | Safia Mahomed
- EMGuidance | Mohammed Dalwai
Session 20C
- Strategies to achieve STI control in South Africa | Remco Peters
- Hepatitis C | Andrew Scheibe
Session 22A
- Care of aging patients | Marlin McKay
- Palliative care | Dave Spencer
Session 22B
- New ARVs and surveillance | Michelle Moorhouse
- Low-dose darunavir | Francois Venter
Session 22C
- Constructing TB cascades to inform TB programme improvement | Kate Rees)
- Continued Use of PrEP among Sex Workers in Six Sites in South Africa | Cara O’Connor
- Linking paediatric, adolescent and adult patients to care through the implementation of clinic navigators in high volume facilities | Chantal Smith
- Perceptions of HIV-Self Screening | Nthabiseng Koloane
- Viral load suppression among pregnant women presenting on ART in antenatal care; Chiredzi District Zimbabwe | Talent Maphosa
- Triple-NRTI regimens while on TB treatment in a resource constrained setting – a paediatric cohort analysis | Jennifer Minnaar
- Youth Care Clubs: Optimising clinic time, fostering peer support, improving adherence | Moira Beery
Session 23A
- Vaccination guidelines | Sipho Dlamini
- Safer conception guidelines | Natasha Davies
- Adult antiretroviral therapy guidelines | Michelle Moorhouse
- Palliative care guidelines | Dave Spencer
Session 23B
- What is new in adherence | Catherine Orrell
- Virological monitoring – how it relates to adherence | Richard Lessells
- Self screening | Naleni Rhagnath
Session 23C
- Quality Improvement | Lauren de Kock
Session 24